Protalix BioTherapeutics Announces AIR DNase(TM) Data Presented at the 38th European Cystic Fibrosis Conference
June 12, 2015 at 07:30 AM EDT
Protalix BioTherapeutics, Inc. (NYSE MKT: PLX) (TASE:PLX) announced today that pre-clinical data for AIR DNaseTM (PRX-110) for the ...